| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Magnolol | Bladder Cancer | 3 | PM | 37549536 | 📋 | Unveiling nature's potential weapon: Magnolol's role in combating bladder cancer by upregulating the miR-124 and inactivating PKC-δ/ERK axis |
| Magnolol | Bladder Cancer | 2 | PM | 33240083 | 📋 | Pharmaceutical Evaluation of Honokiol and Magnolol on Apoptosis and Migration Inhibition in Human Bladder Cancer Cells |
| Magnolol | Bladder Cancer | 1 | PM | 26600425 | 📋 | Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1 |
| Magnolol | Bone Cancer | 1 | PM | 36039427 | 📋 | Magnolol Suppresses ERK/NF-κB Signaling and Triggers Apoptosis Through Extrinsic/Intrinsic Pathways in Osteosarcoma |
| Magnolol | Breast Cancer | 3 | PM | 37103080 | 📋 | Accessing Apoptosis Induction and Metastasis Inhibition Effect of Magnolol on Triple Negative Breast Cancer In Vitro |
| Magnolol | Breast Cancer | 2 | PM | 34885972 | 📋 | Magnolol and Honokiol Inhibited the Function and Expression of BCRP with Mechanism Exploration |
| Magnolol | Breast Cancer | 1 | PM | 11268114 | 📋 | Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis |
| Magnolol | Cancer | 3 | PM | 36234977 | 📋 | Magnolol as a Potential Anticancer Agent: A Proposed Mechanistic Insight |
| Magnolol | Cancer | 1 | PM | 34047218 | 📋 | Natural Lignans Honokiol and Magnolol as Potential Anticarcinogenic and Anticancer Agents. A Comprehensive Mechanistic Review |
| Magnolol | Cancer | 2 | PM | 33050112 | 📋 | Magnolol Enhances the Therapeutic Effects of TRAIL through DR5 Upregulation and Downregulation of c-FLIP and Mcl-1 Proteins in Cancer Cells |
| Magnolol | Cervical Cancer | 1 | PM | 38375055 | 📋 | Magnolol and 5-fluorouracil synergy inhibition of metastasis of cervical cancer cells by targeting PI3K/AKT/mTOR and EMT pathways |
| Magnolol | Colorectal Cancer | 1 | PM | 37326338 | 📋 | Dual targeting of wild-type p53 and gut microbiota by Magnolol represses key metabolic process and kills CRC cells |
| Magnolol | Esophageal Cancer | 1 | PM | 38660717 | 📋 | Magnolol promotes the autophagy of esophageal carcinoma cells by upregulating HACE1 gene expression |
| Magnolol | Gastric Cancer | 2 | PM | 36837487 | 📋 | Evaluating the Magnolol Anticancer Potential in MKN-45 Gastric Cancer Cells |
| Magnolol | Gastric Cancer | 1 | PM | 33183428 | 📋 | Compare the Effects of Magnolol on Gastric Cancer Cells Through c-Jun N-Terminal Kinase Signaling Pathway and Gold Magnetic |
| Magnolol | Glioblastoma | 1 | PM | 34947930 | 📋 | Magnolol Induces the Extrinsic/Intrinsic Apoptosis Pathways and Inhibits STAT3 Signaling-Mediated Invasion of Glioblastoma Cells |
| Magnolol | Glioma | 2 | PM | 37286145 | 📋 | Magnolol and Temozolomide exhibit a synergistic anti-glioma activity through MGMT inhibition |
| Magnolol | Glioma | 1 | PM | 36736226 | 📋 | Magnolol induces cytotoxic autophagy in glioma by inhibiting PI3K/AKT/mTOR signaling |
| Magnolol | Liver Cancer | 2 | PM | 33922992 | 📋 | Induction of Apoptosis, Inhibition of MCL-1, and VEGF-A Expression Are Associated with the Anti-Cancer Efficacy of Magnolol Combined with Regorafenib in Hepatocellular Carcinoma |
| Magnolol | Liver Cancer | 1 | PM | 32850418 | 📋 | 2-O-Methylmagnolol, a Magnolol Derivative, Suppresses Hepatocellular Carcinoma Progression via Inhibiting Class I Histone Deacetylase Expression |
| Magnolol | Lung Cancer | 3 | PM | 35896265 | 📋 | Magnolol Induces Apoptosis Through Extrinsic/intrinsic Pathways and Attenuates NF-κB/STAT3 Signaling in Non-small-cell Lung Cancer Cells |
| Magnolol | Lung Cancer | 2 | PM | 34816662 | 📋 | [Effects of Magnolol combined with Gefitinib on A549 non-small cell lung cancer cells] |
| Magnolol | Lung Cancer | 1 | PM | 27268146 | 📋 | Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer |
| Magnolol | Multiple Myeloma | 1 | PM | 33440989 | 📋 | Magnolol suppressed cell migration and invasion and induced cell apoptosis via inhibition of the NF-κB signaling pathway by upregulating microRNA-129 in multiple myeloma |
| Magnolol | Neuroblastoma | 1 | PM | 35024319 | 📋 | Synergistic effects of autophagy/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacy |
| Magnolol | Oral Cancer | 3 | PM | 34680412 | 📋 | Magnolol Triggers Caspase-Mediated Apoptotic Cell Death in Human Oral Cancer Cells through JNK1/2 and p38 Pathways |
| Magnolol | Oral Cancer | 2 | PM | 33551310 | 📋 | Magnolol inhibits cancer stemness and IL-6/Stat3 signaling in oral carcinomas |
| Magnolol | Oral Cancer | 1 | PM | 32348135 | 📋 | Pharmacokinetic and Metabolic Profiling of Key Active Components of Dietary Supplement Magnolia officinalis Extract for Prevention against Oral Carcinoma |
| Magnolol | Pancreatic Cancer | 1 | PM | 33344246 | 📋 | Magnolol Suppresses Pancreatic Cancer Development In Vivo and In Vitro via Negatively Regulating TGF-β/Smad Signaling |
| Magnolol | Retinoblastoma | 1 | PM | 36603340 | 📋 | Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo |
